Cargando…
Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
Data from the Cancer Genome Atlas (TCGA) are now easily accessible through web-based platforms with tools to assess the prognostic value of molecular alterations. Pancreatic tumors have heterogeneous biology and aggressiveness ranging from the deadly adenocarcinoma (PDAC) to the better prognosis, ne...
Autores principales: | Nicolle, Remy, Raffenne, Jerome, Paradis, Valerie, Couvelard, Anne, de Reynies, Aurelien, Blum, Yuna, Cros, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357157/ https://www.ncbi.nlm.nih.gov/pubmed/30669703 http://dx.doi.org/10.3390/cancers11010126 |
Ejemplares similares
-
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features
por: Raffenne, Jérôme, et al.
Publicado: (2021) -
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status
por: Raffenne, Jerome, et al.
Publicado: (2019) -
DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
por: Decamps, Clémentine, et al.
Publicado: (2021) -
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
por: Nicolle, Rémy, et al.
Publicado: (2020) -
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
por: Dayot, Stéphanie, et al.
Publicado: (2018)